|
So.....?
|
5
|
Resverlogix Corp.
|
Oct 13, 2017 06:12PM
|
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 18, 2017 06:19PM
|
|
Re: Possibile deals for both RVX and Zenith
|
1
|
Resverlogix Corp.
|
Oct 18, 2017 06:37PM
|
|
Re: New article on Apabetalone
|
2
|
Resverlogix Corp.
|
Oct 18, 2017 06:44PM
|
|
Re: Great Presetation today - Transcript
|
5
|
Zenith Epigenetics
|
Oct 25, 2017 11:01PM
|
|
Re: A little social experiment with Google Trends....
|
1
|
Resverlogix Corp.
|
Oct 31, 2017 04:07PM
|
|
RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
10
|
Resverlogix Corp.
|
Dec 14, 2017 10:04AM
|
|
Re: RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
2
|
Resverlogix Corp.
|
Dec 15, 2017 12:07AM
|
|
Re: RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
2
|
Resverlogix Corp.
|
Dec 15, 2017 12:11AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Dec 15, 2017 12:32AM
|
|
Re: ACC 2018 Late Breakers Announce
|
3
|
Resverlogix Corp.
|
Jan 23, 2018 09:16PM
|
|
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:23PM
|
|
A couple from the "Cardiology Top 10" this month.
|
1
|
Resverlogix Corp.
|
Feb 01, 2018 10:09PM
|
|
Here's one while we wait again - inflammation & obesity (huge market)
|
3
|
Resverlogix Corp.
|
Feb 13, 2018 04:53PM
|
|
Another - arthritis/inflammati... & other indications (including cardio) - RCGD 423
|
4
|
Resverlogix Corp.
|
Feb 13, 2018 05:08PM
|
|
A couple pretty recent non-technical ones on apabetalone & FSH
|
5
|
Resverlogix Corp.
|
Apr 04, 2018 09:34PM
|
|
Re: A couple pretty recent non-technical ones on apabetalone & FSH
|
|
Resverlogix Corp.
|
Apr 04, 2018 09:43PM
|
|
Re: Bromodomain-2 Selective BET inhibitors
|
2
|
Resverlogix Corp.
|
Apr 21, 2018 11:09PM
|
|
a couple related to third eye and similar companies
|
1
|
Resverlogix Corp.
|
Apr 21, 2018 11:27PM
|
|
Re: Bromodomain-2 Selective BET inhibitors
|
2
|
Resverlogix Corp.
|
Apr 21, 2018 11:57PM
|
